英国重型β地中海贫血的生存率：来自英国地中海贫血登记处的数据。
Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register.
作者信息
Modell B, Khan M, Darlison M
出版信息
Lancet. 2000 Jun 10;355(9220):2051-2. doi: 10.1016/S0140-6736(00)02357-6.
Abstract
About 50% of UK patients with beta-thalassaemia major die before the age of 35 years, mainly because conventional iron-chelation therapy is too burdensome for full adherence. Patients require an individually-tailored treatment plan incorporating new, more tolerable approaches.
摘要
在英国，约50%的重型β地中海贫血患者在35岁前死亡，主要原因是传统的铁螯合疗法过于繁琐，难以完全坚持。患者需要一个个性化的治疗方案，纳入新的、更易耐受的方法。
Zotero 插件